Back
Marinus Pharmaceuticals Vs. Heron Therapeutics Industry Stock Comparison
Sell
28
MRNS
Marinus Pharmaceuticals
Last Price:
1.29
Seasonality Move:
31.72%
Sell
44
HRTX
Heron Therapeutics
Last Price:
3.47
Seasonality Move:
-4.59%
Sell
28
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy, Sell or Hold?
- The current Marinus Pharmaceuticals [MRNS] share price is $1.17. The Score for MRNS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- MRNS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Heron Therapeutics (HRTX)
is a Sell
Is Heron Therapeutics a Buy, Sell or Hold?
- The current Heron Therapeutics [HRTX] share price is $3.49. The Score for HRTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- HRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MRNS Stock Price Chart
What is Marinus Pharmaceuticals's stock price today?
-
The Marinus Pharmaceuticals share price today is $1.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing slight selling pressure.
HRTX Stock Price Chart
What is Heron Therapeutics's stock price today?
-
The Heron Therapeutics share price today is $3.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HRTX is experiencing slight buying pressure.
MRNS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 25.72 | Sell |
| Chaikin Money Flow: | -1752708 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 1.52) | Sell |
| Bollinger Bands (100): | (1.15 - 8.99) | Sell |
HRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 54.28 | Buy |
| Chaikin Money Flow: | 1819813 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.28 - 3.68) | Buy |
| Bollinger Bands (100): | (2.54 - 3.34) | Buy |
MRNS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.31 | Sell |
| 20-day SMA: | 1.42 | Sell |
| 50-day SMA: | 1.41 | Sell |
| 200-day SMA: | 6.57 | Sell |
| 8-day EMA: | 1.3 | Sell |
| 20-day EMA: | 1.4 | Sell |
| 50-day EMA: | 2.3 | Sell |
| 200-day EMA: | 5.62 | Sell |
HRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.3 | Buy |
| 20-day SMA: | 3.5 | Sell |
| 50-day SMA: | 3.15 | Buy |
| 200-day SMA: | 2.15 | Buy |
| 8-day EMA: | 3.36 | Buy |
| 20-day EMA: | 3.38 | Buy |
| 50-day EMA: | 3.22 | Buy |
| 200-day EMA: | 2.57 | Buy |
Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.24 per share, an increase this year of $0.58 per share, and an increase next year of $0.88 per share.
Heron Therapeutics Earnings Growth & HRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.13 per share.
Marinus Pharmaceuticals Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Heron Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||